NL300118I2 - Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen. - Google Patents

Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.

Info

Publication number
NL300118I2
NL300118I2 NL300118C NL300118C NL300118I2 NL 300118 I2 NL300118 I2 NL 300118I2 NL 300118 C NL300118 C NL 300118C NL 300118 C NL300118 C NL 300118C NL 300118 I2 NL300118 I2 NL 300118I2
Authority
NL
Netherlands
Prior art keywords
factor viiic
protein
compsn
polypeptide
new
Prior art date
Application number
NL300118C
Other languages
English (en)
Other versions
NL300118I1 (nl
Original Assignee
Chiron Corp
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27075219&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300118(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/570,062 external-priority patent/US5004804A/en
Application filed by Chiron Corp, Novo Nordisk As filed Critical Chiron Corp
Publication of NL300118I1 publication Critical patent/NL300118I1/nl
Publication of NL300118I2 publication Critical patent/NL300118I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL300118C 1984-01-12 2003-03-18 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen. NL300118I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/570,062 US5004804A (en) 1984-01-12 1984-01-12 Method and composition for preparation of factor VIIIC
US66491984A 1984-10-26 1984-10-26
EP85100223A EP0150735B2 (en) 1984-01-12 1985-01-11 Protein composition exhibiting coagulation activity and method for the preparation thereof

Publications (2)

Publication Number Publication Date
NL300118I1 NL300118I1 (nl) 2003-06-02
NL300118I2 true NL300118I2 (nl) 2004-06-01

Family

ID=27075219

Family Applications (4)

Application Number Title Priority Date Filing Date
NL300118C NL300118I2 (nl) 1984-01-12 2003-03-18 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
NL300119C NL300119I1 (nl) 1984-01-12 2003-03-18 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-contructen.
NL300120C NL300120I1 (nl) 1984-01-12 2003-03-18 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
NL300153C NL300153I1 (nl) 1984-01-12 2004-06-25 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.

Family Applications After (3)

Application Number Title Priority Date Filing Date
NL300119C NL300119I1 (nl) 1984-01-12 2003-03-18 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-contructen.
NL300120C NL300120I1 (nl) 1984-01-12 2003-03-18 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
NL300153C NL300153I1 (nl) 1984-01-12 2004-06-25 Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.

Country Status (7)

Country Link
EP (3) EP1006182A3 (nl)
JP (5) JPH0826078B2 (nl)
AT (2) ATE78871T1 (nl)
DE (6) DE3588242T2 (nl)
DK (3) DK165506C (nl)
LU (4) LU91013I2 (nl)
NL (4) NL300118I2 (nl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
EP0162067B1 (en) * 1983-10-28 1992-07-15 Genetics Institute, Inc. Production of factor viii and related products
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
EP0182448A3 (en) * 1984-08-24 1987-10-28 Genetics Institute, Inc. Production of factor viii and related products
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
AU5772886A (en) * 1985-04-12 1986-11-05 Genetics Institute Inc. Novel procoagulant proteins
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
FI98829C (fi) * 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
EP0251843A1 (fr) * 1986-06-06 1988-01-07 Transgene S.A. Procédé de préparation de facteur VIII à partir de cellules de mammifères
JP2593500B2 (ja) * 1986-06-24 1997-03-26 ノルデイスク ゲントフテ エー／エス ▲ｖｉｉｉ▼因子フラグメントの凝固活性複合物の製造方法
DE3769872D1 (de) 1986-07-11 1991-06-13 Miles Inc Herstellung von rekombinantem protein.
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
IL84168A0 (en) * 1986-10-15 1988-03-31 Rorer Int Overseas Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same
AU606925B2 (en) * 1987-01-30 1991-02-21 Biogen, Inc. A method for producing factor viii in high yield
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0690126B1 (en) 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
DE3737239A1 (de) * 1987-11-03 1989-10-12 Behringwerke Ag Gentechnische herstellung von anticoagulatorischem protein pp4
US6544771B1 (en) * 1987-12-11 2003-04-08 Cell Genesys, Inc. Retroviral gene therapy vectors and therapeutic methods based thereon
US6140111A (en) * 1987-12-11 2000-10-31 Whitehead Institute For Biomedical Research Retroviral gene therapy vectors and therapeutic methods based thereon
JPH05500512A (ja) * 1989-09-14 1993-02-04 バクスター　インターナショナル　インコーポレーテッド 薬学的組成物を製造するための方法および装置
US5610033A (en) * 1990-04-25 1997-03-11 Novo Nordisk A/S Method of producing proteins with FVIII activity and/or FVIII derivatives
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
CA2276091A1 (en) * 1996-12-27 1998-07-09 Mochida Pharmaceutical Co., Ltd. Cell membrane-directed drugs
EP1154796B1 (en) 1999-02-22 2007-06-20 University of Connecticut Novel albumin-free factor viii formulations
US7220718B2 (en) 2001-08-03 2007-05-22 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oral treatment of hemophilia
WO2004035789A1 (en) * 2002-10-18 2004-04-29 Lg Life Sciences Ltd. Gene families associated with cancers
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
WO2011095604A1 (en) 2010-02-04 2011-08-11 Octapharma Biopharmaceuticals Gmbh Half-life prolongation of proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
IE80638B1 (en) * 1983-03-31 1998-10-21 Scripps Research Inst Monoclonal antibodies to new factor VIII coagulant polypeptides
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
EP0162067B1 (en) * 1983-10-28 1992-07-15 Genetics Institute, Inc. Production of factor viii and related products
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
JPH0634760A (ja) * 1992-07-15 1994-02-10 Hamamatsu Photonics Kk 放射線計測装置及び核医学診断装置

Also Published As

Publication number Publication date
LU91087I2 (fr) 2004-08-26
ATE224445T1 (de) 2002-10-15
NL300153I1 (nl) 2004-09-01
EP1006182A3 (en) 2000-06-14
JPH04218399A (ja) 1992-08-07
DK13585A (da) 1985-09-11
JP2000023670A (ja) 2000-01-25
DK13585D0 (da) 1985-01-11
EP0466199A1 (en) 1992-01-15
EP0466199B1 (en) 2002-09-18
EP0150735B2 (en) 2004-01-07
LU91014I2 (fr) 2003-06-19
DE3588242D1 (de) 2002-10-31
NL300118I1 (nl) 2003-06-02
DK150992A (da) 1992-12-17
DK169708B1 (da) 1995-01-16
NL300120I1 (nl) 2003-06-02
DK165506C (da) 1993-04-19
NL300119I1 (nl) 2003-06-02
DK165506B (da) 1992-12-07
LU91015I2 (fr) 2003-06-19
EP1006182A2 (en) 2000-06-07
DK169724B1 (da) 1995-01-23
DK38892A (da) 1992-03-25
DE10399010I1 (de) 2003-10-23
DK38892D0 (da) 1992-03-25
JPH0634760B2 (ja) 1994-05-11
JPS60185723A (ja) 1985-09-21
DE3586402D1 (de) 1992-09-03
LU91013I2 (fr) 2003-06-19
EP0150735A3 (en) 1987-07-01
JPH06105688A (ja) 1994-04-19
JP2002186487A (ja) 2002-07-02
DE3586402T3 (de) 2004-12-23
DE122004000028I1 (de) 2004-09-30
DE3588242T2 (de) 2004-03-11
JPH0826078B2 (ja) 1996-03-13
EP0150735A2 (en) 1985-08-07
DE10399009I1 (de) 2003-10-23
DE3586402T2 (de) 1993-01-07
DE10399011I1 (de) 2003-10-23
ATE78871T1 (de) 1992-08-15
EP0150735B1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
NL300118I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
DE3786200D1 (de) Diagnostische verfahren zum nachweis von lymphomen bei menschen.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
ATE157545T1 (de) Antigene proteine und diese enthaltende impfstoffe zur verhütung von kokzidiose
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE69426209D1 (de) Stannius- körperchen -protein, stanniocalcin
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
KR860006484A (ko) 단백질 또는 당단백질의 제조방법
NO962596L (no) Nytt tumorsupressorgen
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
KR950018049A (ko) 사람 dna 토포이소머라제 제i형의 돌연변이체 단백질
ATE134218T1 (de) Methode zur reinigung rekombinanter t-pa von den ihren entsprechenden wirtszellproteinen